H.R. 2821 · 119TH CONGRESSHouse · Jun 18, 2026
FDA Modernization Act 3.0
Take Action
Introduced
House
Senate
Resolving Differences
President
Became Law
Description
FDA Modernization Act 3.0
Step 2 of 6 · House
FDA Modernization Act 3.0
Jul 9, 2025 · 14:15
No additional details are available for this hearing yet.
Jul 16, 2025 · 10:00
| Name | Position | Links |
|---|---|---|
| Dr. Candice ChenU.S. Health Resources and Services Administration | Acting Associate Administrator for Health Workforce | |
| Dr. Jacqueline Corrigan-CurayU.S. Food and Drug Administration | Acting Director for Center for Drug Evaluation and Research (CDER) | |
| Mr. Tom MorrisU.S. Health Resources and Services Administration | Associate Administrator for Rural Health Policy |
Referred to the Subcommittee on Health.
Apr 10, 2026
Subcommittee Consideration and Mark-up Session Held
May 13, 2026
Forwarded by Subcommittee to Full Committee by Voice Vote.
May 13, 2026
May 13, 2026 · 14:00
Committee Consideration and Mark-up Session Held
May 21, 2026
Ordered to be Reported by the Yeas and Nays: 44 - 0.
May 21, 2026
May 21, 2026 · 10:00
Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
Jun 18, 2026
Reported by the Committee on Energy and Commerce. H. Rept. 119-706.
Jun 18, 2026
Placed on the Union Calendar, Calendar No. 614.
Jun 18, 2026